CLPTM1L expression predicts recurrence of patients with intermediate‑ and high‑risk stage IB‑IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy-Reference-Cited by-同舟云学术

CLPTM1L expression predicts recurrence of patients with intermediate‑ and high‑risk stage IB‑IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy

Published:2023-07-04 Issue:2 Volume:26 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Awazu Yuichiro¹,Fukuda Takeshi²,Noda Takuya¹,Uchikura Eijiro¹,Nanno Shigenori¹,Imai Kenji²,Yamauchi Makoto²,Yasui Tomoyo²,Sumi Toshiyuki²

Affiliation:

1. Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Osaka, Osaka 5454‑8585, Japan

2. Department of Obstetrics and Gynecology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Osaka 5454‑8585, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference35 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. NCCN guidelines insights: Cervical cancer, version 1.2020;Abu-Rustum;J Natl Compr Canc Netw,2020

3. Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer;Ebina;Int J Clin Oncol,2019

4. Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067);Matoda;Gynecol Oncol,2018

5. Adjuvant chemotherapy, a valuable alternative option in selected patients with cervical cancer;Li;PLoS One,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting recurrence in intermediate‑ and high‑risk stage IB‑IIB cervical cancer treated with adjuvant cisplatin and paclitaxel chemotherapy post‑radical hysterectomy: The role of TBX2 expression;Oncology Letters;2024-06-28